| 227 | 7 | 161 |
| 下载次数 | 被引频次 | 阅读次数 |
目的探讨处方前置审核、药学干预和行政干预组成的多模式干预对帕瑞昔布临床应用合理性的影响。方法根据建立的帕瑞昔布药物利用评价(DUE)标准进行回顾性研究,采用属性层次模型(AHM)法对干预前随机抽取的200例帕瑞昔布归档病例的合理性进行评价。对不合理问题采取多模式干预,采用AHM法对干预后随机抽取的200例帕瑞昔布归档病例合理性进行评价。对干预前后病例的合理性进行分析,进而对多模式干预的效果进行讨论。结果干预前病例平均得分(75.17±17.28)分,干预后病例平均得分(79.41±15.69)分,干预前后病例得分经t检验,差异具有统计学意义(P <0.05)。结论多模式干预可利用各自的优点,相互协作,在促进帕瑞昔布的临床合理应用上具有一定的作用,特别是禁忌、疗效及联合用药。
Abstract：AIM To explore the effect of multi-modal intervention composed of pre-prescription review,pharmaceutical intervention and administrative intervention on the rationality of parecoxib in clinical application.METHODS A retrospective study was conducted based on the established parecoxib drug use evaluation(DUE) criteria,and the rationality evaluation of 200 archived cases of parecoxib selected randomly before the intervention was evaluated by analytic hierarchical model(AHM) method. Unreasonable problems were intervened by multi-modal intervention, then the rationality of 200 cases of parecoxib randomly selected after the intervention was evaluated by AHM method. Analyze the rationality of cases before and after intervention, and then discuss the effects of multi-modal intervention. RESULTS The average score before the intervention was(75.17±17.28). After the intervention, the average score was(79.41±15.69).The medical record score before and after intervention were tested by t test(P < 0.05), which was statistically significant.CONCLUSION Multi-modal intervention can take advantage of their respective advantages and cooperate with each other to play a certain role in promoting the rational clinical application of parecoxib, especially in contraindication,efficacy and combination medication.
[1]张秀果,韩霜,杜彦茹.帕瑞昔布钠对开胸手术患者术后炎症反应及苏醒期的影响[J].医药导报,2019,38(6):738.
[2]冷希圣,韦军民,刘连新,等.普通外科围手术期疼痛处理专家共识[J].中华普通外科杂志,2015,9(2):166.
[3]宋佳伟,陈慧娟,施朕善,等.帕瑞昔布药物利用评价标准的建立及应用[J].中国新药与临床杂志,2020,39(11):683.
[4]宋佳伟,陈慧娟,施朕善,等.基于Granada-Ⅱ分类法评价临床应用注射用帕瑞昔布钠的药物相关问题[J].中国临床药学杂志,2020,29(6):432.
[5]杨晓.药师干预对住院患者抗菌药物使用合理性的影响[J].临床合理用药杂志,2020,13(3):177.
[6]廖丽娜,刘玲,陈潞梅,等.处方前置审核系统在提高中成药临床合理用药中的作用[J].中国医院药学杂志,2020,40(19):2069.
[7]杨延风,马俊杰.基于属性层次分析模型(AHM)的乡村旅游餐饮服务质量的多主体评价实证研究[J].中国农业资源与区划,2019,40(2):188.
[8]王庆东,侯海军.属性层次模型AHM在质量评估中的应用[J].数学的实践与认识,2006,36(1):98.
[9]庞进丽.基于属性层次模型的岗位工资排序[J].信阳师范学院学报(自然科学版),2015,28(2):267.
[10]曹永梅,李君,李廉俊.基于属性层次模型的灌区节水水平研究[J].人民黄河,2017,39(9):145.
[11]彭军.基于属性层次模型的商业银行内部控制评价[J]商业经济研究,2015(17):78.
[12]The European Society for Emergency Medicine.Guidelines for the management of acute pain in emergency situations [EB/OL].(2010-11-22)[2020-03-01].https://eusem.org/images/EUSEM_EPI GUIDELINES MARCH 2020.pdf.
[13]宋佳伟,张庆,徐珊珊,等.基于加权TOPSIS法的癌痛规范化治疗合理性评价[J].中国医院药学杂志,2018,38(17):1856.
[14]宋佳伟,李春贤,施朕善,等.基于加权TOPSIS法评价与药学干预对癌痛治疗效果的分析[J].中南药学,2019,17(2):281.
[15]宋佳伟,刘丽,徐珊珊,等.基于加权TOPSIS法的艾迪注射液合理性评价[J].中南药学,2019,17(1):125.
[16]MOTOV S, STRAYER R, HAYES B D, et al.The treatment of acute pain in the emergency department:a white paper position statement prepared for the American academy of emergency medicine [J].J Emerg Med,2018,54(5):731.
[17]王国林,仓静,邓小明,等.成年人非阿片类镇痛药围手术期应用专家共识[J].国际麻醉学与复苏杂志,2019,40(1):1.
[18]胡夕春,王杰军,常建华,等.癌症疼痛诊疗上海专家共识(2017年版)[J].中国癌症杂志,2017,27(4):312.
[19]徐建国.成人手术后疼痛处理专家共识[J].临床麻醉学杂志,2017,33(9):911.
[20]国家卫生健康委员会医管中心加速康复外科专家委员会,浙江省医师协会临床药师专家委员会,浙江省药学会医院药学专业委员会.中国加速康复外科围手术期非甾体抗炎药临床应用专家共识[J].中华普通外科杂志,2019,34(3):283.
[21]仇晓娟,陈锴,胡彬,等.帕瑞昔布钠在术后镇痛中应用的研究进展[J].现代生物医学进展,2018,18(2):385.
基本信息:
DOI：10.19577/j.1007-4406.2021.06.008
中图分类号:R969.3
引用信息:
[1]宋佳伟,王媛媛,陈慧娟,等.多模式干预对帕瑞昔布临床应用合理性的影响[J].中国临床药学杂志,2021,30(06):433-437.DOI:10.19577/j.1007-4406.2021.06.008.
基金信息:
亳州市人民医院2020年度院级科研项目(编号By202025);亳州市人民医院2020年度三项项目(编号2020YB-57)
2021-11-25
2021-11-25